Diebold Nixdorf (DBD) Earnings Analysis

Diebold Nixdorf (DBD) next reports earnings on 2026-07-29, consensus EPS 1.1 USD. Last quarter (2026-04-30) it missed with EPS 0.6 USD vs 0.61 USD est (-1.6%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E 29.13.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does DBD next report earnings?

Next earnings date2026-07-29
Consensus EPS estimate1.1 USD
Revenue estimate0.92B

DBD earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-300.6 USD0.61 USD-1.6%Miss
2026-02-123.02 USD1.61 USD+87.6%Beat
2024-11-070.53 USD1.36 USD-61%Miss

Beat rate: 1/3 (33%) over reported quarters with consensus data.

DBD valuation and analyst view

Trailing P/E29.13
Trailing EPS3.074 USD
Price / book2.99
Dividend yield0.00%
Market cap3.00B
Analyst consensusBuy (5 buy / 5 hold / 3 sell)
Avg price target90 USD

Related research pages

Frequently asked questions

When is Diebold Nixdorf (DBD)'s next earnings date?

Diebold Nixdorf is next scheduled to report on 2026-07-29, with a consensus EPS estimate of 1.1 USD and revenue estimate of 0.92B.

Did DBD beat earnings last quarter?

In its 2026-04-30 report, DBD posted EPS of 0.6 USD versus a 0.61 USD estimate — a miss of 1.6%.

What is DBD's earnings track record?

Over the last 3 reported quarters with consensus data, DBD beat estimates 1 times (33%).

What is DBD's current P/E ratio and EPS?

DBD trades at a trailing P/E of 29.13 on trailing EPS of 3.074074074074074 USD.

What do analysts rate DBD?

Analyst consensus is "Buy" across 13 ratings (0 strong buy, 5 buy, 5 hold, 3 sell, 0 strong sell). Average 12-month price target: 90 USD.